NasdaqCM - Nasdaq Real Time Price USD
Citius Oncology, Inc. (CTOR)
As of 10:45 AM EDT. Market Open.
Breakdown
9/30/2023
9/30/2022
Total Assets
47,734.8950
42,690.1820
Total Liabilities Net Minority Interest
22,199.2350
6,422.7810
Total Equity Gross Minority Interest
25,535.6600
36,267.4010
Total Capitalization
25,535.6600
36,267.4010
Common Stock Equity
25,535.6600
36,267.4010
Net Tangible Assets
-14,464.3400
-3,732.5990
Working Capital
-13,312.3400
-3,156.5990
Invested Capital
25,535.6600
36,267.4010
Tangible Book Value
-14,464.3400
-3,732.5990
Share Issued
71,239.8000
71,239.8000
Ordinary Shares Number
71,239.8000
71,239.8000
9/30/2022 - 12/8/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SXTC China SXT Pharmaceuticals, Inc.
0.6688
-0.18%
UPC Universe Pharmaceuticals INC
0.3699
-8.51%
SNOA Sonoma Pharmaceuticals, Inc.
2.8100
-5.39%
PRFX PainReform Ltd.
0.7600
+2.69%
YCBD cbdMD, Inc.
0.4801
-7.66%
SBFM Sunshine Biopharma, Inc.
3.0200
-1.31%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
1.3901
+7.76%
CPHI China Pharma Holdings, Inc.
0.2331
-0.81%
TLPH Talphera, Inc.
1.0100
-0.98%
BFRI Biofrontera Inc.
0.9487
+0.64%